3.2. Stress and anxiety assessments
±, anxiety disorder, SD, anxiety
GAD-7 and PSS scores were assessed at the baseline (day 0), visit 3 (day 30), and final visit (day 60) for all the participants. Figure Stress and anxiety assessments.Data is represented as Mean ± SD. The difference between the 2 treatment groups were compared using 2 -way repeated measure analysis of variance (RMANOVA) with Bonferroni post hoc test at 3 different time points. Time × treatment variation and degree of freedom = 2, for RM ANOVA is represented in the table.ARE = Ashwagandha root extract, F = the ratio of the variance between the groups to the variance within the groups, GAD7 = generalized anxiety disorder, PSS = perceived stress score, SS = sums of squares.The mean GAD-7 and PSS scores at day 0 days 30 and 60 in the placebo and ARE groups. Repeated measures 1-way analysis of variance (ANOVA) with Tukey Multiple Comparison Test showed a significant difference from baseline to day 30 and day 60 in ARE. *